Office: Cambridge, MA

Executive Assistant:
Sarah Parker
(617) 949-2176

Barry Gertz, MD, PhD

Dr. Gertz joined Clarus in October 2014 from Merck (MRK) where he was Senior Vice President and Head of Global Clinical Development, overseeing all aspects of Merck’s clinical research. He brings 28 years of experience in drug development, from exploratory clinical pharmacology to global phase 3 trials. While at Merck Dr. Gertz was instrumental in the development and approval of more than 25 new drugs and vaccines, including the blockbuster products Fosamax and Januvia. Dr. Gertz has co-authored over a hundred scientific publications appearing in the Journal of Clinical Investigation, the Journal of Clinical Endocrinology and Metabolism, and the New England Journal of Medicine.

Dr. Gertz received an MD, PhD, and BA from the University of Pennsylvania.

Clarus Board Seats